Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,691
Total Claims
$806K
Drug Cost
660
Beneficiaries
$1,222
Cost/Patient
Risk Score Breakdown 55/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,194 Neurology providers
+3161%
Opioid rate vs peers
42.6% vs 1.3% avg
-70%
Cost per patient vs peers
$1,222 vs $4,034 avg
-48%
Brand preference vs peers
4.9% vs 9.4% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
42.6%
Opioid Rate
4,133
Opioid Claims
$143K
Opioid Cost
5.3%
Long-Acting Rate
This provider's opioid prescribing rate of 42.6% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 474 claims · $481K
Generic: 9,188 claims · $324K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Interferon Beta-1a/Albumin | 13 | $123K |
| Hydrocodone/Acetaminophen | 3,224 | $95K |
| Glatiramer Acetate | 13 | $57K |
| Erenumab-Aooe | 37 | $35K |
| Topiramate | 46 | $32K |
| Topiramate | 24 | $30K |
| Ubrogepant | 27 | $30K |
| Brivaracetam | 20 | $30K |
| Cenobamate | 24 | $28K |
| Oxcarbazepine | 26 | $25K |
| Vortioxetine Hydrobromide | 35 | $17K |
| Perampanel | 13 | $16K |
| Eslicarbazepine Acetate | 12 | $16K |
| Gabapentin | 773 | $14K |
| Carbidopa/Levodopa | 29 | $13K |
Prescribing Profile
86
Unique Drugs
55.0
Anomaly Score
Patient Profile
67
Avg Age
60%
Female
1.98
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About